What is TMS?

Transcranial Magnetic Stimulation (TMS) therapy is FDA-approved for the treatment of Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), and migraines. While TMS is not FDA-approved specifically for Post-Traumatic Stress Disorder (PTSD), it has been used “off-label” by many physicians who have found it effective in reducing PTSD symptoms.

At Central California TMS Center, we specialize in providing TMS therapy to individuals with MDD who have not responded adequately to traditional treatments. TMS is a non-invasive procedure that uses magnetic fields to stimulate specific areas of the brain involved in mood regulation. It is a personalized and evidence-based approach, backed by regulatory approval and numerous clinical studies demonstrating its efficacy.

Our clinic utilizes the MagVenture TMS device, which is FDA-cleared for treating adults with MDD who have not responded to antidepressant medications. We follow the repetitive Transcranial Magnetic Stimulation (rTMS) protocol, which delivers magnetic pulses to the left dorsolateral prefrontal cortex to modulate brain activity. This protocol typically involves stimulation at 10–20 Hz, administered five days a week over a 6–8 week period. In a clinical study conducted by AwakeningsKC Clinical Neuroscience Institute (CNI), a 72% remission rate was observed in MDD patients treated with MagVenture rTMS therapy.